2020
Changes In Apparent Diffusion Coefficient (ADC) In Serial Weekly MRI During Radiotherapy In Patients With Head And Neck Cancer: Results From The PREDICT-HN Study
Ng S, Cardenas C, Bahig H, Elgohari B, Wang J, Johnson J, Moreno A, Shah S, Garden A, Phan J, Gunn G, Frank S, Ding Y, Na L, Yuan Y, Urbauer D, Rosenthal D, Morrison W, MacManus M, Fuller C. Changes In Apparent Diffusion Coefficient (ADC) In Serial Weekly MRI During Radiotherapy In Patients With Head And Neck Cancer: Results From The PREDICT-HN Study. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e790-e791. DOI: 10.1016/j.ijrobp.2020.07.264.Peer-Reviewed Original Research
2019
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy
Ng S, Pollard C, Berends J, Ayoub Z, Kamal M, Garden A, Bahig H, Cantor S, Schaefer A, Ajayi T, Gunn G, Frank S, Skinner H, Phan J, Morrison W, Ferrarotto R, Johnson J, Mohamed A, Lai S, Hessel A, Sturgis E, Weber R, Fuller C, Rosenthal D. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer 2019, 125: 1823-1829. PMID: 30748005, PMCID: PMC7234834, DOI: 10.1002/cncr.31983.Peer-Reviewed Original ResearchConceptsDisease recurrenceAsymptomatic patientsOverall survivalClinical findingsNeck cancerAdverse clinical findingsLocoregional disease recurrenceMedian imaging followUsefulness of surveillanceDisease-free intervalMedian overall survivalDistant disease recurrenceGroup of patientsEfficacy of surveillanceTreatment of HNCEligible patientsSalvage therapySalvageable recurrenceDefinitive radiotherapyMedian timeSuspicious findingsPatientsRecurrenceRadiotherapyEarly detection